FDA advisory committee calls for more data on selinexor for relapsed multiple myeloma - Healio

FDA advisory committee calls for more data on selinexor for relapsed multiple myeloma  Healio

An FDA advisory committee determined the approval of selinexor for treatment of patients with heavily pretreated multiple myeloma should be delayed until ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more